FTC says prescription middlemen are squeezing Main Street pharmacies
CBSN
Prescription drug middlemen — also known as pharmacy benefit managers — are lining their pockets by inflating drug prices, including overcharging cancer patients, the Federal Trade Commission said Tuesday.
"The FTC's interim report lays out how dominant pharmacy benefit managers can hike the cost of drugs — including overcharging patients for cancer drugs," FTC Chair Lina M. Khan said in a news release. "The report also details how PBMs can squeeze independent pharmacies that many Americans — especially those in rural communities — depend on for essential care."
Pharmacy Benefit Managers began, decades ago, as administrators, validating and processing pharmacy benefits provided by separate insurance plans. After years of acquisitions, that's no longer the case, as the FTC lays out in its report.

The Federal Communication Commission announced Thursday evening that it had approved the $6.2 billion merger of major broadcast station owners Nexstar and Tegna. The move came on the same day that attorneys general in eight states and DirecTV filed separate lawsuits seeking to block the deal, arguing that it will lead to higher prices for consumers and stifle local journalism. In:

Washington — A group of senators met with border czar Tom Homan on Thursday as negotiators continue to seek an agreement to reform Immigration and Customs Enforcement and end the shutdown of the Department of Homeland Security. Nikole Killion, Alan He and Caitlin Huey-Burns contributed to this report.











